2026 NPPES data Hematology & Oncology Physician NPI 1285709055 PA
Verify on CMS →

RACHEL MAGLOIRE, PA

Hematology & Oncology Physician in BROOKLYN, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
195
Medicare Part D claims · 48 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
64%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.5K
110 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

RACHEL MAGLOIRE, PA filed 195 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in BROOKLYN, New York, prescribing 64% generic.

195
Part D claims, 2023
64%
generic prescribing
$2.5K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RACHEL MAGLOIRE, PA's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

195 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

RACHEL MAGLOIRE, PA practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RACHEL MAGLOIRE, PA?

Quality data not reported

NPI registry status

Active

Issued 11/21/2006

NPI 1285709055

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

195 77% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in New York

How Hematology & Oncology Physician compares to other specialties among New York providers

New York providers

Hematology & Oncology Physician share within New York

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RACHEL MAGLOIRE, PA appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding PA credentials at 4802 10TH AVE, BROOKLYN, NY, 11219, with a listed phone of (718) 283-8773. NPI 1285709055 was issued on 11/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MAGLOIRE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 195 prescription claims written by this provider, covering 48 Medicare beneficiaries and totaling roughly $838K in drug spend, split 36% brand-name and 64% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4802 10TH AVE
BROOKLYN, NY 11219

Provider Details

NPI 1285709055
Specialty Hematology & Oncology Physician
Credentials PA
Gender Female
NPI Issued 11/21/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RACHEL MAGLOIRE, PA. Source: openpaymentsdata.cms.gov.

Total received

$2.5K

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to RACHEL MAGLOIRE, PA. To verify RACHEL MAGLOIRE, PA's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

RACHEL MAGLOIRE, PA — brand share 36.0%
Specialty average (est.)

36% brand-name claims vs 64% generic, on 195 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

195
Total Claims
$838K
Total Drug Cost
48
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
209
Total Day Supply
5,522
Brand vs Generic
36% brand / 64% generic
Brand Drug Cost
$797K
Generic Drug Cost
$41K

Patient Demographics

Average Patient Age
74.0 years
Avg HCC Risk Score
3.08
Gender Split
65% female / 35% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RACHEL MAGLOIRE, PA prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Eliquis
Apixaban
22
Promacta
Eltrombopag Olamine
21
Hydroxyurea
18
Xarelto
Rivaroxaban
16
Dexamethasone
12
Potassium Chloride
12
Prednisone
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How RACHEL MAGLOIRE, PA fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

RACHEL MAGLOIRE, PA's 195 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as MAGLOIRE.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RACHEL MAGLOIRE, PA's specialty?
RACHEL MAGLOIRE, PA specializes in Hematology & Oncology Physician and practices in BROOKLYN, New York. Credentials: PA.
How much does RACHEL MAGLOIRE, PA prescribe under Medicare Part D?
In 2023, RACHEL MAGLOIRE, PA wrote 195 Medicare Part D claims totaling $838K in drug costs for 48 beneficiaries.
Where is RACHEL MAGLOIRE, PA located?
RACHEL MAGLOIRE, PA is located at 4802 10TH AVE, BROOKLYN, NY, 11219. Phone: (718) 283-8773.
What is RACHEL MAGLOIRE, PA's NPI number?
RACHEL MAGLOIRE, PA's National Provider Identifier (NPI) is 1285709055, issued on 11/21/2006.
Does RACHEL MAGLOIRE, PA prescribe more brand-name or generic drugs?
RACHEL MAGLOIRE, PA's prescribing is 36% brand-name and 64% generic drugs by claim count, with $797K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does RACHEL MAGLOIRE, PA prescribe most often?
Based on 2023 Medicare Part D data, RACHEL MAGLOIRE, PA's most frequently prescribed drugs include Eliquis, Promacta, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RACHEL MAGLOIRE, PA accept Medicare?
RACHEL MAGLOIRE, PA appears in CMS Medicare data with 195 Part D claims and 48 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RACHEL MAGLOIRE, PA's credentials?
RACHEL MAGLOIRE, PA's NPI is 1285709055 with credentials PA. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology